New gel could mean fewer applications for knee pain relief
NCT ID NCT06729073
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested how much of the pain-relieving drug diclofenac enters the bloodstream when applied as a gel to the knees. 34 healthy volunteers used a new once-daily gel (AMZ001) and a standard four-times-daily gel for 7 days each. The goal was to compare drug levels and check safety, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nuvisan
Neu-Ulm, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?